InsiderTrades

Form 4 for EW Edwards Lifesciences

Accepted 2023-04-06 00:00:00 ET · period of report 2023-04-06 · accession 0001225208-23-004762 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-04-06 2023-04-06 EW BOBO DONALD E JR CVP, Strategy, Corp Development M - OptEx $35.20 +6,725 69.5K +11% +$236.7K
D 2023-04-06 2023-04-06 EW BOBO DONALD E JR CVP, Strategy, Corp Development S - Sale+OE $83.09 -6,725 62.8K -10% -$558.8K
D 2023-04-06 2023-04-06 EW BOBO DONALD E JR CVP, Strategy, Corp Development M - OptEx $0.00 -6,725 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-04-06 M A 6,725 $35.20 69,548.69 D — —
2 Common Common Stock 2023-04-06 S D 6,725 $83.09 62,823.69 D — — (F2) This transaction was executed in multiple trades at prices ranging from $82.80 to $83.45 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
3 Derivative Employee Stock Option (Right to Acquire) 2023-04-06 M D 6,725 $0.00 0 D $35.20 · 2017-05-12 to 2023-05-11 6,725 Common Stock